Tonix Pharma (TNXP) Misses Q2 EPS by 215c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.68), $2.15 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• Lowe's slashes full-year sales outlook amid DIY spending pressure